Review



repaglinide ddi minimal oral  (Simcyp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Simcyp repaglinide ddi minimal oral
    Summary of PBPK models published for P450 Sensitive Substrates
    Repaglinide Ddi Minimal Oral, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/repaglinide ddi minimal oral/product/Simcyp
    Average 90 stars, based on 1 article reviews
    repaglinide ddi minimal oral - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification "

    Article Title: Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification

    Journal: Drug Metabolism and Disposition

    doi: 10.1124/dmd.115.065920

    Summary of PBPK models published for P450 Sensitive Substrates
    Figure Legend Snippet: Summary of PBPK models published for P450 Sensitive Substrates

    Techniques Used: Software, In Vitro, In Vivo

    Summary of the PBPK models published for transporter substrates, inhibitors and inducers
    Figure Legend Snippet: Summary of the PBPK models published for transporter substrates, inhibitors and inducers

    Techniques Used: Software, In Vivo, In Vitro



    Similar Products

    repaglinide ddi minimal oral  (Simcyp)
    90
    Simcyp repaglinide ddi minimal oral
    Summary of PBPK models published for P450 Sensitive Substrates
    Repaglinide Ddi Minimal Oral, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/repaglinide ddi minimal oral/product/Simcyp
    Average 90 stars, based on 1 article reviews
    repaglinide ddi minimal oral - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of PBPK models published for P450 Sensitive Substrates

    Journal: Drug Metabolism and Disposition

    Article Title: Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification

    doi: 10.1124/dmd.115.065920

    Figure Lengend Snippet: Summary of PBPK models published for P450 Sensitive Substrates

    Article Snippet: D 1 Simcyp ( Zhao et al., 2012a ) Repaglinide DDI Minimal Oral PE No N.S B, E 1 Napp ( Kudo et al., 2013 ) Repaglinide DDI Full Oral BC No N.S C,E 1 Simcyp ( Varma et al., 2013 ) CYP2C19 Clobazam Pediatrics Full Oral In vitro No N.S.

    Techniques: Software, In Vitro, In Vivo

    Summary of the PBPK models published for transporter substrates, inhibitors and inducers

    Journal: Drug Metabolism and Disposition

    Article Title: Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification

    doi: 10.1124/dmd.115.065920

    Figure Lengend Snippet: Summary of the PBPK models published for transporter substrates, inhibitors and inducers

    Article Snippet: D 1 Simcyp ( Zhao et al., 2012a ) Repaglinide DDI Minimal Oral PE No N.S B, E 1 Napp ( Kudo et al., 2013 ) Repaglinide DDI Full Oral BC No N.S C,E 1 Simcyp ( Varma et al., 2013 ) CYP2C19 Clobazam Pediatrics Full Oral In vitro No N.S.

    Techniques: Software, In Vivo, In Vitro